Novo Nordisk wins EU approval for Wegovy pill and new injection
Go back to Novo Nordisk wins EU approval for Wegovy pill and new injection| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 48.18 -0.01 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.19 | 52 Week High | $59.00 | |||
| Open | $48.38 | 52 Week Low | $32.80 | |||
| Day High | $48.93 | P/E | N/A | |||
| Day Low | $48.11 | EPS | $0.00 | |||
| Volume | 8,224,025 | |||||
